Journal article

Choosing and sequencing novel drugs in CLL: dealing with an embarrassment of riches?

CS Tam, JF Seymour

Annals of Oncology | OXFORD UNIV PRESS | Published : 2017

DOI: 10.1093/annonc/mdx103

Citation metrics

Keywords

Oncology
Idelalisib
Fludarabine
Science & Technology
Initial Therapy
Life Sciences & Biomedicine
Chronic Lymphocytic-Leukemia
Cyclophosphamide
Venetoclax
Ibrutinib
Regimen
Rituximab